Burton, MI - October 15,2014 - InvestorsHub NewsWire - Sanomedics International Holdings, Inc. (OTCQB: SIMH) is a medical technology holding company that focuses on game changing products, services and ideas; a place where physicians, entrepreneurs, and medical companies can work together to drive innovative technologies through concept, development, and ultimately commercialization. Sanomedics plans to grow existing business organically and through strategic acquisitions specifically relating to healthcare technology and services.

View the report at the link to see how the company’s Thermomedics division’s Caregiver Touchfree thermometer is being deployed to ports of entry to detect fevers: http://bit.ly/-SIMH-AnalystReport

Hemispherx BioPharma, Inc. (NYSE-MKT: HEB) is an advanced specialty pharmaceutical company. Hemispherx's flagship products include Alferon N Injection(R) and the experimental therapeutics Ampligen(R) and Alferon(R) LDO. Ampligen(R) is an experimental RNA nucleic acid being developed for globally important debilitating diseases and disorders of the immune system, including Chronic Fatigue Syndrome. Hemispherx's platform technology includes components for potential treatment of various severely debilitating and life threatening diseases.

Read about the company’s collaborations to battle the Ebola virus, along with a detailed report on the virus at this link: http://bit.ly/-HEB-AnalystReport

GenuFoods Energy Enzyme Corp. (OTCBB: GFOO) is a development stage company. They distribute an enzyme dietary supplement for human and animal consumption. ProCellax and ProAnilax are brands owned by them and are trade mark registered in the United States of America, China, Hong Kong, Macau, Taiwan, Thailand, Malaysia, Singapore and Sri Lanka.      

Get your full analyst Report here: http://bit.ly/-GFOO-AnalystReport

Creative Edge Nutrition, Inc. (OTCBB: FITX) is a holding company and a Nutritional Supplement Company focused on developing innovative, high quality supplements. The company offers a broad spectrum of capsules, tablets, and powders, as well as science based products in the principal categories of weight management, nutrition challenges, energy and fitness. The Company manufactures under strict GMP guidelines at GMP Certified and/or FDA registered facilities. CEN Biotech, Inc. is a partially owned subsidiary of FITX for the sole purpose of supplying the Canadian public with pharmaceutical-grade medical cannabis

For information and updates regarding the company’s cannabis business follow the link to read a full report: http://bit.ly/-FITX-AnalystReport

About Small Cap Street
Once you read our reports written by our team of financial analysts you will understand that we make every effort to provide informative equity research reports for interested parties at no cost.

Our Financial Analysts spend countless hours researching stocks. They include stocks traded in the NYSE, NASDAQ, and OTCBB exchanges. These reports include a straightforward assessment of the company by a financial analyst who has pledged to remain free of influence when writing research reports.

FORWARD-LOOKING DISCLAIMER
This report may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward- looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of mentioned company to be materially different from the statements made herein.

A full disclaimer can be found by viewing the full analyst report.

If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at editor@smallcapstreet.com. For any urgent concerns or inquiries please contact us at editor@smallcapstreet.com.

Source: Small Cap Street, LLC

 
 

Genufood Energy Enzymes (CE) (USOTC:GFOO)
過去 株価チャート
から 11 2024 まで 12 2024 Genufood Energy Enzymes (CE)のチャートをもっと見るにはこちらをクリック
Genufood Energy Enzymes (CE) (USOTC:GFOO)
過去 株価チャート
から 12 2023 まで 12 2024 Genufood Energy Enzymes (CE)のチャートをもっと見るにはこちらをクリック